NDC 60219-1714 – Lenalidomide
Lenalidomide 2.5 mg/1 · Capsule · Oral
Product NDC60219-1714
Product details
- Brand name
- Lenalidomide
- Generic name
- Lenalidomide
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA216213
- Marketed since
- February 12, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Thalidomide Analog
Active ingredients
- Lenalidomide 2.5 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 60219-1714-1 | 28 CAPSULE in 1 BOTTLE (60219-1714-1) | Feb 12, 2025 |
| 60219-1714-2 | 100 CAPSULE in 1 BOTTLE (60219-1714-2) | Feb 12, 2025 |
Other Lenalidomide products
- 16729-695 Lenalidomide 15 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-697 Lenalidomide 25 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-693 Lenalidomide 5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-696 Lenalidomide 20 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-692 Lenalidomide 2.5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-694 Lenalidomide 10 mg/1 · Capsule · Accord Healthcare Inc.
- 47781-486 Lenalidomide 15 mg/1 · Capsule · Alvogen, Inc.
- 47781-488 Lenalidomide 25 mg/1 · Capsule · Alvogen, Inc.
- 47781-484 Lenalidomide 5 mg/1 · Capsule · Alvogen, Inc.
- 47781-483 Lenalidomide 2.5 mg/1 · Capsule · Alvogen, Inc.
- 47781-487 Lenalidomide 20 mg/1 · Capsule · Alvogen, Inc.
- 47781-485 Lenalidomide 10 mg/1 · Capsule · Alvogen, Inc.